Evidence map›Paper›PMID 28534161›Full record

Observational studyCalcified tissue international2017

Autoantibodies to Osteoprotegerin are Associated with Low Hip Bone Mineral Density and History of Fractures in Axial Spondyloarthritis: A Cross-Sectional Observational Study.

Barbara Hauser, Sizheng Zhao, Micaela R Visconti, Philip L Riches, William D Fraser, Isabelle Piec, Nicola J Goodson, Stuart H Ralston

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Calcified tissue international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Osteoimmunology of Spondyloarthritis.International journal of molecular sciences · 2023
    Review
  3. Review
  4. Review
  5. B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Osteoporosis in Rheumatic Diseases.International journal of molecular sciences · 2019
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Barbara HauserCentre for Genomics and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Sizheng ZhaoDepartment of Academic Rheumatology, Aintree University Hospital, Liverpool, L9 7AL, UK.
Micaela R ViscontiCentre for Genomics and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Philip L RichesCentre for Genomics and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
William D FraserDepartment of Medicine, University of East Anglia, Norwich, UK.
Isabelle PiecDepartment of Medicine, University of East Anglia, Norwich, UK.
Nicola J GoodsonDepartment of Academic Rheumatology, Aintree University Hospital, Liverpool, L9 7AL, UK. ngoodson@liverpool.ac.uk.
Stuart H RalstonCentre for Genomics and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
University of Edinburgh · GBUniversity of East Anglia · GBUniversity of Liverpool · GB

Funding

Arthritis Research UKMedical Research Council G0701603Versus Arthritis 19299
6 · The paper itself

Abstract

Osteoporosis is a recognised complication of axial spondyloarthritis (axSpA) and is thought to be due to functional impairment and the osteoclast-activating effects of proinflammatory cytokines. The development of autoantibodies to OPG (OPG-Ab) has been associated with severe osteoporosis and increased bone resorption in rheumatoid arthritis. In this study, we screened for the presence of OPG-Ab in axSpA and reviewed their clinical significance. We studied 134 patients, recruited from two centres in the United Kingdom. Their mean age was 47.5 years and 75% were male. Concentrations of OPG-Ab were related to bone mineral density (BMD) and fracture history using linear and logistic regression models adjusting for age, gender, disease duration and activity, body mass index and bisphosphonate use. We detected OPG-Ab in 11/134 patients (8.2%). Femoral neck and total hip BMD were significantly reduced in OPG-Ab positive patients (0.827 vs. 0.967 g/cm

Indexed as

AutoantibodiesAutoantigensBone DensityCross-Sectional StudiesFemaleFractures, BoneHipHumansMaleMiddle AgedOsteoporosisOsteoprotegerinSpondylarthritisAutoantibodiesAutoantigensOsteoprotegerinTNFRSF11B protein, humanAnkylosing spondylitisAxial spondyloarthritisBone mineral densityOsteoporosisOsteoprotegerin

Identifiers

PMID28534161
PMCPMC5587630
OpenAlexW2615587273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.